JD Health
| Company type | Public |
|---|---|
| Industry | Digital health, Medical services |
| Founded | 2014 |
| Headquarters | China |
Area served | China |
| Parent | JD.com |
JD Health (JDH; ) is a Hong Kong-listed Chinese enterprise focusing on digital health solutions. It functions as the medical services division within JD.com.
History
Established in 2014 as an independent segment of JD's healthcare business, JDH secured funding from investors such as Hillhouse Investment.
In August 2020, JDH introduced 'JD Family Doctor,' a telehealth platform designed to provide ongoing, tailored medical support for families comprising up to eight individuals. This service enabled round-the-clock access to general practitioners through various communication methods, including prescription fulfillment and hospital appointment scheduling. Despite substantial capital infusion and an ambition to reach 50 million households within five years, the initiative faced profitability challenges and opposition from public hospital physicians, ultimately resulting in its discontinuation in May 2024.
JD Health debuted on the Hong Kong Stock Exchange in December 2020 through an initial public offering that raised US$3.5 billion—ranking as the second-largest Hong Kong IPO that year following a secondary listing by its parent company. On its first trading day, shares jumped by 75%, reflecting robust investor interest. The surge in online medical consultations during the COVID-19 pandemic saw JDH managing over 100,000 daily consultations at its peak.
By June 2023, JDH gained inclusion in the Hang Seng Index, marking its recognition in the market.